MDXG News and Press, MiMedx Group Inc From 05/02/23

2023-05-02 23:08:05 ET MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Conference Call May 02, 2023 05:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group ...

2023-05-02 16:12:01 ET MiMedx Group press release ( NASDAQ: MDXG ): Q1 GAAP EPS of -$0.06 beats by $0.03 . Revenue of $71.68M (+21.7% Y/Y) beats by $7.53M . The Company continues to believe the business is capable of delivering sales growth in the low double-di...

First Quarter Net Sales of $71.7 Million Reflect an Increase of 21.7% Over the Prior Year Period Revenue Growth & Cost Controls Help Drive Improvements in Net Loss, EBITDA & Adjusted EBITDA 1 Management to Host Conference Call on Tuesday, May&...

2023-05-01 17:35:56 ET MiMedx Group ( NASDAQ: MDXG ) is scheduled to announce Q1 earnings results on Tuesday, May 2nd, after market close. The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is $64.15M (+8.9% Y/Y). For further details see: MiM...

MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 ...

2023-03-23 16:28:35 ET MiMedx ( MDXG ) said Thursday Peter Carlson will step down as the company's chief financial officer. The company has initiated a search for its next CFO. Carlson will be assisting MIMEDX throughout the CFO search process to ensure a smooth trans...

MARIETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company to pursue othe...

MARIETTA, Ga., March 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today applauded the recent report published by OIG entitled, “Some Skin Substitute Manufacturers Did Not...

MiMedx Group, Inc. (MDXG) Q4 2022 Results Conference Call February 28, 2023 05:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group Carl Byrnes - Northla...

MiMedx Group press release ( NASDAQ: MDXG ): Q4 GAAP EPS of -$0.02. Revenue of $74.38M (+10.4% Y/Y). For further details see: MiMedx Group GAAP EPS of -$0.02, revenue of $74.38M